Close

BTIG Remains Neutral on Merrimack Pharma (MACK) Following Q3 Report, Restructuring

Go back to BTIG Remains Neutral on Merrimack Pharma (MACK) Following Q3 Report, Restructuring
MERRIMACK PHARM (NASDAQ: MACK) Delayed: 14.75 +0.03 (0.20%)
Previous Close $14.72    52 Week High $9.63 
Open $14.75    52 Week Low $4.39 
Day High $14.80    P/E N/A 
Day Low $14.72    EPS $-1.24 
Volume 129,206